RVL-101

N/A

Report date: 2024/05/22 17:31:33
NME

Base Information

Drug NameRVL-101
Drug Alias NameRVL-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionT-cell surface antigen CD4 inhibitorsT-cell differentiation antigen CD6 inhibitors
TargetsT-cell surface antigen CD4T-cell differentiation antigen CD6
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesReverie Labs Inc
China Registration ClassN/A

Develop Information

Active CompaniesReverie Labs Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A